earnings call

By Laura Lovett August 10, 2018
Shortly after launching its integrated continuous glucose monitoring system, Dexcom announced a 42 percent increase in year-over-year sales during its Q2 earnings call.  “Not only did we exceed our annual growth guidance for the second consecutive quarter but the business continues to accelerate,” Kevin Ronald Sayers, CEO of Dexcom, said during the call. “All of our key segments demonstrated...
By Dave Muoio August 10, 2018
The second quarter of 2018 was a strong one for the rapidly expanding DarioHealth. Touting 70 percent year-over-year revenue growth and a continued decline in its cash burn rate, CEO Erez Raphael credited his company’s increasing fortune to recent US regulatory approvals and product launches as well as the company’s wider focus on an integrated consumer experience. “Overall, we made an...
By Laura Lovett August 9, 2018
Not two months after getting the FDA nod for its implantable CGM, Eversense, Senseonics held its Q2 earnings call reporting a increase in year over year revenues. However, it continues to operate at a net loss. “In a matter of just six short weeks, we’ve accomplished a lot. We’ve received the authorization from the agency to commercialize in the US, we launched our US commercial activities...
By Dave Muoio August 2, 2018
It was a bit of a bumpy start, but it’s beginning to look like Fitbit’s push into the smartwatch market is beginning to bear fruit. While the company is still operating at a loss, yesterday’s Q2 earnings report revealed that the Fitbit’s downward revenue and device sales trend was lessened by the success of its Versa smartwatch, which the company said has outsold all Samsung, Garmin, and Fossil’s...
By Jonah Comstock July 31, 2018
This story has been updated with some additional information about the layoffs. Wal-Mart has decided to part ways with Castlight Health at the conclusion of its current contract rather than migrate over to Castlight Complete, the company's new platform designed to bring the consumer-facing care navigation tools it rolled out with Anthem Engage out to non-Anthem customers. On the company's second...
By Dave Muoio July 25, 2018
Clinical trial technology company Medidata boasted consistent gains in revenue and income for the second quarter of 2018 during yesterday’s earnings call to investors. Referencing these numbers, last month’s acquisition of Shyft Analytics, recent high-profile contracts, and increased recognition from industry analysts, Medidata CEO and Chairman Tarek Sherif said that his company is performing...
By Dave Muoio July 19, 2018
Earnings reports shared by neurostimulation and digital medicine company NeuroMetrix during a Q2 investors’ call showed a slight drop in total revenue as the company is preparing to place its marketing weight behind the launch of its updated wearable pain relief product, Quell. However, the company remained profitable during the quarter thanks to sales of its other product, DPNCheck. Dr. Shai N....

Credit:

By Laura Lovett May 25, 2018
Dexcom started out the year strong following the FDA clearance of its integrated continuous glucose monitor the G6. In its Q1 earnings call, the company reported a 30 percent increase in revenue compared to Q1 of 2017, bringing its total revenue to $184 million. When the FDA gave Dexcom the nod for the G6 it became the first interoperable CGM to get the designation. According to the earnings call...
By Laura Lovett May 3, 2018
Despite the expected declining sales numbers, Fitbit affirmed its focus on digital health, during its Q1 earnings call. In particular the company is now looking to its latest Google collaboration, where the two companies will work on refining EHRs to give clinicians a more comprehensive look into patient data, to speed up innovation in the digital health space.  “First, Fitbit and Google are...
By Dave Muoio May 3, 2018
Amidst big gains in total revenue, memberships, and user engagement, Q1 2018 earnings reported by Teladoc show that the telemedicine company is still a long way from turning a profit. But while this quarter’s reported net loss of $23.9 million is a noticeable increase over the $15.7 million of the same time last year, CEO Jason Gorevic said during an investor call that the company is still on...
www.dopingman.com.ua/tabletirovannyie-steroidyi/stanozolol/stanabol-forte.html

https://pillsbank.net

подробно poliv.ua